ES2188644T3 - Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas. - Google Patents

Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas.

Info

Publication number
ES2188644T3
ES2188644T3 ES95402155T ES95402155T ES2188644T3 ES 2188644 T3 ES2188644 T3 ES 2188644T3 ES 95402155 T ES95402155 T ES 95402155T ES 95402155 T ES95402155 T ES 95402155T ES 2188644 T3 ES2188644 T3 ES 2188644T3
Authority
ES
Spain
Prior art keywords
wrinkles
treatment
glycine
receiver associated
chlorine channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95402155T
Other languages
English (en)
Inventor
Lacharriere Olivier De
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9467477&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2188644(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2188644T3 publication Critical patent/ES2188644T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE UNA O VARIAS SUSTANCIAS AGONISTAS DE UNO O VARIOS RECEPTORES ASOCIADOS A UN CANAL DE CLORO EN UNA COMPOSICION COSMETICA Y/O DERMATOLOGICA, PARA SOLTAR Y/O RELAJAR EL TEJIDO CUTANEO, PARTICULARMENTE PARA TRATAR LAS ARRUGAS Y LAS ARRUGILLAS DE LA PIEL. LA COMPOSICION SEGUN LA INVENCION PUEDE UTILIZARSE POR VIA TOPICA O INYECTABLE. LA SUSTANCIA AGONISTA DE UN RECEPTOR ASOCIADO A UN CANAL DE CLORO SE ELIGE PARTICULARMENTE EN EL GRUPO QUE COMPRENDE GLICINA, SERINA, TAURINA, {BE}ALANINA, N{(BENCILOXICARBONIL-GLICINA {(Z-GLICINA, EL ACIDO GAMMAAMINOBUTIRICO (GABA), ISOGUVACINA, ACIDO ISONIPECOTICO, 4,5,6,7TETRA-HIDROISOXAZOLO-{(5,4-CPIRIDIN-3{(2H-ONA, LAS BENZODIACEPINAS, LOS ESTEROIDES Y LOS BARBITURICOS. LA COMPOSICION PUEDE TAMBIEN CONTENER ADEMAS UN RETINOIDE Y/O UN HIDROXIACIDO.
ES95402155T 1994-09-30 1995-09-26 Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas. Expired - Lifetime ES2188644T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411742 1994-09-30

Publications (1)

Publication Number Publication Date
ES2188644T3 true ES2188644T3 (es) 2003-07-01

Family

ID=9467477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95402155T Expired - Lifetime ES2188644T3 (es) 1994-09-30 1995-09-26 Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas.

Country Status (12)

Country Link
US (2) US5869068A (es)
EP (1) EP0704210B1 (es)
JP (1) JP2736316B2 (es)
KR (1) KR100280242B1 (es)
CN (1) CN1109537C (es)
AT (1) ATE228834T1 (es)
BR (1) BR9504741A (es)
CA (1) CA2159555C (es)
DE (1) DE69529043T2 (es)
ES (1) ES2188644T3 (es)
HU (1) HUT73064A (es)
RU (1) RU2128497C1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0704210B1 (fr) * 1994-09-30 2002-12-04 L'oreal Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
FR2767692B1 (fr) * 1997-09-01 2000-03-03 Oreal Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles
KR19990040469A (ko) * 1997-11-18 1999-06-05 손경식 피부 화장료 조성물
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
FR2793681B1 (fr) * 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
US6753315B2 (en) * 2000-02-24 2004-06-22 Brown University Research Foundation α-bungarotoxin molecules and uses thereof
FR2815860B1 (fr) * 2000-10-26 2003-12-12 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou precurseur ou derive de celle-ci et au moins un agent myorelaxant
GB0113348D0 (en) * 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
WO2003053466A1 (fr) * 2001-12-13 2003-07-03 Shiseido Company, Ltd. Accelerateurs de reparation de la fonction barriere de la peau
FR2847469B1 (fr) * 2002-11-26 2006-04-07 Oreal Utilisation de l'adenosine ou d'un analogue d'adenosine, pour lisser les rides d'expression
FR2859908A1 (fr) * 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
JP5241058B2 (ja) * 2003-11-27 2013-07-17 株式会社 資生堂 不全角化抑制剤及び毛穴縮小剤
KR20120062681A (ko) * 2003-11-27 2012-06-14 가부시키가이샤 시세이도 부전각화 억제제 및 피부 외용 조성물
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
US20100239655A1 (en) * 2004-12-09 2010-09-23 Georgia Levis Taurine-based compositions and therapeutic methods
FR2879451B1 (fr) * 2004-12-20 2007-05-04 Oreal Utilisation de ligands du recepteur des benzodiazepines pour lutter contre les signes du vieillissement
BRPI0517216A (pt) * 2004-12-20 2008-09-30 Oreal uso cosmético de pelo menos um antagonista dos receptores periféricos das benzodizepinas e processo cosmético para combater as rugas ou as rìdulas
ES2259928B1 (es) 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
JP4865251B2 (ja) 2005-05-09 2012-02-01 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物
CA2621365C (en) 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
JP4838537B2 (ja) * 2005-05-25 2011-12-14 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤又は肌荒れ防止・改善剤及び皮膚外用組成物
CN101227885A (zh) 2005-07-26 2008-07-23 株式会社资生堂 皱纹防止·改善剂
WO2007034750A1 (ja) * 2005-09-22 2007-03-29 Shiseido Company, Ltd. しわ改善剤
KR100862969B1 (ko) * 2007-03-05 2008-10-13 바이오스펙트럼 주식회사 바르비투르산을 유효성분으로 포함하는 피부 미백제
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
US20100297182A1 (en) * 2009-05-20 2010-11-25 Tozzi Donna M Injectable Amino-acid Composition
US9101538B2 (en) 2009-05-20 2015-08-11 Donna M. Tozzi Injectable amino-acid composition
FR2953716B1 (fr) 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
US20110305735A1 (en) 2010-06-09 2011-12-15 Lipotec, S.A. Skin antiaging treatment
JP5254417B2 (ja) * 2011-10-07 2013-08-07 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤及び肌荒れ防止・改善剤
US10406088B2 (en) * 2015-01-20 2019-09-10 TetraDerm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
JP2018514570A (ja) 2015-05-01 2018-06-07 ロレアル 化学処理における活性剤の使用
JP6873994B2 (ja) 2015-11-24 2021-05-19 ロレアル 毛髪を処置するための組成物
CN108495686A (zh) 2015-11-24 2018-09-04 欧莱雅 用于处理毛发的组合物
US11135150B2 (en) 2016-11-21 2021-10-05 L'oreal Compositions and methods for improving the quality of chemically treated hair
FR3061002B1 (fr) 2016-12-23 2019-05-24 L'oreal Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside
KR20170002342A (ko) 2016-12-23 2017-01-06 주식회사 행남생활건강 초고강도 자기 조성물 및 이의 제조방법
US11433011B2 (en) 2017-05-24 2022-09-06 L'oreal Methods for treating chemically relaxed hair
EP4011355A1 (en) 2017-12-29 2022-06-15 L'oreal Compositions for altering the color of hair
US11090249B2 (en) 2018-10-31 2021-08-17 L'oreal Hair treatment compositions, methods, and kits for treating hair
US11419809B2 (en) 2019-06-27 2022-08-23 L'oreal Hair treatment compositions and methods for treating hair
JPWO2022039190A1 (es) * 2020-08-18 2022-02-24
KR20230080056A (ko) * 2021-11-29 2023-06-07 (주)아모레퍼시픽 릴린 및/또는 vegf-c의 생산 및/또는 활성 촉진제 및 이를 이용한 피부 외용제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (es) * 1974-10-19 1978-07-03
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS60184005A (ja) * 1984-03-02 1985-09-19 Kanebo Ltd 皮膚老化防止用化粧料
AU5772686A (en) * 1985-04-22 1986-11-18 Avon Products Inc. Composition and method for reducing wrinkles
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
FR2633515B1 (fr) * 1988-06-30 1992-04-10 Clarins Composition cosmetique pour l'hydratation de la peau
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
DE69103487T2 (de) * 1990-07-11 1995-02-16 Quest Int Parfümierte strukturierte Emulsionen in Körperpflegemitteln.
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
FR2679788B1 (fr) * 1991-08-02 1994-03-18 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
RU2013088C1 (ru) * 1991-08-09 1994-05-30 Ольга Олеговна Ромашко Крем для ухода за сухой и нормальной кожей лица и способ его приготовления
JP3078051B2 (ja) * 1991-08-19 2000-08-21 鐘紡株式会社 皮膚老化防止化粧料
CA2078712A1 (en) * 1991-09-23 1993-03-24 Bernhard Sixt Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation
EP0704210B1 (fr) * 1994-09-30 2002-12-04 L'oreal Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides

Also Published As

Publication number Publication date
EP0704210A3 (fr) 1997-04-23
CN1130059A (zh) 1996-09-04
KR100280242B1 (ko) 2001-02-01
CA2159555C (fr) 2001-07-31
RU2128497C1 (ru) 1999-04-10
BR9504741A (pt) 1996-10-15
US5869068A (en) 1999-02-09
US5976559A (en) 1999-11-02
CN1109537C (zh) 2003-05-28
JPH0899862A (ja) 1996-04-16
HU9502870D0 (en) 1995-11-28
JP2736316B2 (ja) 1998-04-02
EP0704210A2 (fr) 1996-04-03
DE69529043D1 (de) 2003-01-16
EP0704210B1 (fr) 2002-12-04
HUT73064A (en) 1996-06-28
KR960009996A (ko) 1996-04-20
DE69529043T2 (de) 2003-05-08
CA2159555A1 (fr) 1996-03-31
ATE228834T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
ES2188644T3 (es) Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas.
ES2191102T3 (es) Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
BR9710536A (pt) Isobutilgaba e seus derivados para o tratamento da dor
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
DE60101339D1 (de) Stimulierung des knochenwachstums mit peptidderivaten von thrombin
EP1186293A3 (en) Intermittent administration of a growth hormone secretagogue
DE69825447D1 (de) Gerät zur dermatologischen behandlung
TR200101208T2 (tr) Seçici COX-2 inhibitörleri olarak pirazolopiridin türevleri
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
CY2009002I2 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
TR199900505T2 (es)
DE59901629D1 (de) Garnbehandlungseinrichtung sowie verwendung derselben
EP1054900A4 (en) THERAPEUTIC USE OF THE KERATINOCTENT GROWTH FACTOR-2
FI973023L (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20005548D0 (no) Mykobakterieinhibitorer
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
AU2002212896A1 (en) N-type calcium channel antagonists for the treatment of pain
KR970004278U (ko) 마사지용 지압구
NO985558D0 (no) Ny forbedret formulering for behandling av tromboembolisme
KR970019618U (ko) Tv 전원 버튼의 스프링 장착구조
GT199200025A (es) Material de medicamento adecuado para micronizacion
DK9600453U1 (da) Indretning til behandling af sygdomme i anus